| dc.creator |
AKAR, SERVET |
|
| dc.creator |
Cetin, Pinar |
|
| dc.creator |
KALYONCU, UMUT |
|
| dc.creator |
KARADAĞ, ÖMER |
|
| dc.creator |
Sari, Ismail |
|
| dc.creator |
Cinar, Muhammed |
|
| dc.creator |
Yilmaz, Sedat |
|
| dc.creator |
Kisacik, Bunyamin |
|
| dc.creator |
Onat, Ahmet Mesut |
|
| dc.creator |
Erden, Abdulsamet |
|
| dc.creator |
Balkarli, Ayse |
|
| dc.creator |
Senel, Soner |
|
| dc.creator |
Kucuksahin, Orhan |
|
| dc.creator |
Oner, Sibel Yilmaz |
|
| dc.creator |
TUFAN, ABDURRAHMAN |
|
| dc.creator |
Direskeneli, Haner |
|
| dc.creator |
Oksuz, Ferhat |
|
| dc.creator |
Pehlivan, Yavuz |
|
| dc.creator |
Bayindir, Ozun |
|
| dc.creator |
KESER, GÖKHAN |
|
| dc.creator |
AKSU, KENAN |
|
| dc.creator |
Omma, Ahmet |
|
| dc.creator |
KAŞİFOĞLU, TİMUÇİN |
|
| dc.creator |
Yildiz, Fatih |
|
| dc.creator |
Balci, Mehmet Ali |
|
| dc.creator |
Yavuz, Sule |
|
| dc.creator |
ERTEN, ŞÜKRAN |
|
| dc.creator |
Ozgen, Metin |
|
| dc.creator |
Sayarlioglu, Mehmet |
|
| dc.creator |
Unal, Ali Ugur |
|
| dc.creator |
DOĞRU, Atalay |
|
| dc.creator |
Yildirim, Gozde |
|
| dc.creator |
Oner, Fatma Alibaz |
|
| dc.creator |
Tezcan, Mehmet Engin |
|
| dc.creator |
Pamuk, Omer Nuri |
|
| dc.creator |
ÖNEN, FATOŞ |
|
| dc.date |
2018-06-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:36:06Z |
|
| dc.date.available |
2020-10-06T09:36:06Z |
|
| dc.identifier |
2a81b14c-f986-4f44-b34e-b5ede267389b |
|
| dc.identifier |
10.1002/acr.23446 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/2a81b14c-f986-4f44-b34e-b5ede267389b/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/56121 |
|
| dc.description |
ObjectiveApproximately 30-45% of patients with familial Mediterranean fever (FMF) have been reported to have attacks despite colchicine treatment. Currently, data on the treatment of colchicine-unresponsive or colchicine-intolerant FMF patients are limited; the most promising alternatives seem to be anti-interleukin-1 (anti-IL-1) agents. Here we report our experience with the off-label use of anti-IL-1 agents in a large group of FMF patients. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/openAccess |
|
| dc.title |
Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients |
|
| dc.type |
info:eu-repo/semantics/article |
|